ATHERSYS, INC.

Athersys Prices Public Offering of Common Stock

Athersys Prices Public Offering of Common Stock

RRY Publications to host a summit

Developers of Drugs for Deadly or Debilitating Diseases Could See Faster FDA Pathway

Athersys Presents New Data Demonstrating Potential Benefits From MultiStem After Spinal Cord Injury

Athersys says new data demonstrate potential benefits from MultiStem

Athersys Presents New Data Demonstrating Potential Benefits From MultiStem After Spinal Cord Injury

Piper Jaffray's biotech/specialty pharma research team hold conference call

Publication Indicates That MultiStem Treatment May Reduce Inflammation and Promote Reparative Proce

Publication Indicates That MultiStem Treatment May Reduce Inflammation and Promote Reparative Processes Following Acute Brain Injury